In a filing, Atyr Pharma Inc revealed its Director Gross Jane A acquired Company’s shares for reported $15000.0 on Mar 17 ’25. In the deal valued at $4.00 per share,3,750 shares were bought. As a result of this transaction, Gross Jane A now holds 9,750 shares worth roughly $33540.0.
Then, Broadfoot Jill Marie sold 1,254 shares, generating $4,740 in total proceeds. Upon selling the shares at $3.78, the Chief Financial Officer now owns 31,763 shares.
Before that, DENYES NANCY sold 899 shares. Atyr Pharma Inc shares valued at $3,398 were divested by the General Counsel at a price of $3.78 per share. As a result of the transaction, DENYES NANCY now holds 26,555 shares, worth roughly $91349.2.
Leerink Partners initiated its Atyr Pharma Inc [ATYR] rating to an Outperform in a research note published on February 18, 2025; the price target was $16. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Wells Fargo began covering ATYR with “an Overweight” recommendation on October 04, 2024. Jefferies started covering the stock on September 05, 2024. It rated ATYR as “a Buy”.
Price Performance Review of ATYR
On Monday, Atyr Pharma Inc [NASDAQ:ATYR] saw its stock jump 5.20% to $3.44. Over the last five days, the stock has gained 6.17%. Atyr Pharma Inc shares have fallen nearly -4.97% since the year began. Nevertheless, the stocks have risen 79.63% over the past one year.
How much short interest is there in Atyr Pharma Inc?
A steep rise in short interest was recorded in Atyr Pharma Inc stocks on 2025-04-30, growing by 3.37 million shares to a total of 11.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 8.32 million shares. There was a rise of 28.82%, which implies that there is a positive sentiment for the stock.
